Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human Plasma
Therapeutic Drug Monitoring - United States
doi 10.1097/ftd.0b013e318185813d
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)